Stockreport

Monopar Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Developments

Monopar Therapeutics Inc.  (MNPR) 
PDF WILMETTE, Ill., March 31, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovativ [Read more]